Intestinal Stricture Clinical Trial
Official title:
Paclitaxel-Coated Balloon for the Treatment of Symptomatic Recurrent Benign Intestinal Stricture
POISE I study is a feasibility study for evaluating the safety and efficacy of DCB.
The study is designed to determine the safety and effectiveness for drug coated balloon (DCB) for treating intestinal strictures. Up to 15 subjects are planned to be enrolled and treated with the study device at up to 5 clinical sites outside of US. Subjects will be followed up post-treatment to one year and then annually for up to 5 years. The annual follow up after the first year is optional. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05387031 -
Efficacy of Ustekinumab-based Integrated Medicine Therapy in Patients With Symptomatic Stricturing Crohn's Disease
|